Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TDENV-PIV with AS03B Adjuvant in Healthy Adults
NCT02421367Phase 2Completed
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Aug 2015
- Primary completion
- Dec 2016
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of TDENV-PIV in dengue fever, sponsored by U.S. Army Medical Research and Development Command. Started Aug 2015; status: completed.
02
Drugs
TDENV-PIV
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT02421367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02421367.